EXPLANATORY STATEMENT
National Health Act 1953
National Health (Pharmaceutical Benefits) Regulations (Amendment)
Apart from section 140 of the National Health Act 1953 (the Act), which provides that the Governor-General may make Regulations for the purposes of the Act, certain other provisions in the Act also specifically provide for matters to be prescribed by regulation. Paragraph 105(a) of the Act provides that the regulations may prescribe the terms and conditions subject to which pharmaceutical benefits may be supplied.
The Social Welfare Legislation (Pharmaceutical Benefits) Amendment Act 1990 (the Amendment Act) alters the current Pharmaceutical Benefits Scheme Safety Net whereby persons who purchase more than 25 pharmaceutical benefits per year at the general rate of $11 may, by applying for a Pharmaceutical Benefits Scheme Entitlement Card, receive pharmaceutical benefits free for the remainder of the year. Under this Scheme, concessional beneficiaries pay $2.50 for each of the 25 prescriptions while pensioners receive all pharmaceutical benefits free. The new Scheme, put into place by the Amendment Act, substitutes a graduated monetary Safety Net limit for the existing numerical limit of 25 pharmaceutical benefits per year. The concessional pharmaceutical benefits rate will remain at $2.50. Pensioners will now be included in this class of beneficiary, and no longer receive pharmaceutical benefits free of charge.
The amendments make a number of changes to the National Health (Pharmaceutical Benefits) Regulations consequential on changes to the Scheme contained in the the Amendment Act. The amendment to regulation 9B reflects the new monetary Safety Net limits by replacing the “number of prescriptions” with the “value of the pharmaceutical benefits”. Other amendments are consequential on definitional changes effected by the Amendment Act and eliminate references to pensioners as a separate category of pharmaceutical beneficiary.
Regulations 9C, 9D and 9E have been replaced with regulations which set out the procedures contained in the existing Regulations in a more logical manner.
Overview
The National Health Act 1953, enacted by the Australian Parliament, serves to provide a framework for the administration of health-related benefits and services. It was designed to address the need for a structured system to deliver health benefits, particularly in the area of pharmaceuticals. One significant amendment to this Act came in the form of the Social Welfare Legislation (Pharmaceutical Benefits) Amendment Act 1990, which sought to overhaul the Pharmaceutical Benefits Scheme Safety Net. This amendment aimed to replace the previous system, which capped the number of pharmaceutical benefits at 25 per year at a general rate of $11, with a new graduated monetary Safety Net limit. The policy objective behind this change was to provide a more equitable and financially sustainable pharmaceutical benefits scheme, ensuring that the costs are more appropriately shared among beneficiaries while maintaining access to essential medications.
Scope and Application
The National Health (Pharmaceutical Benefits) Regulations (Amendment) pertains to the regulations governing the Pharmaceutical Benefits Scheme (PBS) under the National Health Act 1953. This legislative amendment applies to all persons and entities involved in the supply and procurement of pharmaceutical benefits, including pharmaceutical manufacturers, suppliers, pharmacies, and patients who utilise the PBS. It impacts the healthcare and pharmaceutical industries by modifying the terms and conditions of the PBS, particularly focusing on the Safety Net threshold that caps the amount an individual must spend on pharmaceutical benefits before qualifying for subsidies. The Act applies nationally across Australia, encompassing all states and territories. However, specific implementation details may vary slightly between jurisdictions to align with state-level health services and regulations. The amendments exclude certain medications and treatments not covered under the PBS. Additionally, certain classes of pharmaceutical products, such as those used in hospitals, are not subject to the PBS and therefore not affected by these regulations. The National Health (Pharmaceutical Benefits) Regulations can be further extended or restricted through subordinate instruments issued under the authority of the Act.
Key Provisions
The main operative sections of the National Health (Pharmaceutical Benefits) Regulations (Amendment) relate to the changes in the Pharmaceutical Benefits Scheme (PBS) Safety Net as outlined in the Social Welfare Legislation (Pharmaceutical Benefits) Amendment Act 1990. Section 105(a) of the National Health Act 1953 permits the regulation of the terms and conditions under which pharmaceutical benefits are supplied, which is central to these amendments. Regulation 9B has been amended to reflect the new monetary Safety Net limit, replacing the numerical limit of 25 prescriptions with a monetary value. This change is pivotal for determining the threshold at which individuals become eligible for the Safety Net, ensuring that the scheme now operates based on the total value of pharmaceutical benefits purchased rather than the number of prescriptions.
The amendments impose several obligations on the parties involved, particularly those administering the PBS. Under the new regulations, entities must calculate the value of pharmaceutical benefits supplied to individuals and compare this against the specified Safety Net thresholds. This necessitates accurate record-keeping and reporting to ensure compliance with the new regulatory framework. Furthermore, the amendments require that the distinction between concessional beneficiaries and pensioners be removed, with all concessional beneficiaries now paying the same rate of $2.50 per prescription after reaching their Safety Net threshold. This unified approach simplifies the administration of the scheme and ensures consistency in the application of benefits.
Breaches of the new regulations may result in civil or criminal consequences, depending on the nature and severity of the non-compliance. For instance, incorrect calculation or reporting of pharmaceutical benefits could lead to financial penalties. The maximum penalties for such offences are not explicitly stated in the explanatory statement, but they would typically be outlined in the Act itself or in related legislation. Additionally, individuals or entities found to be deliberately circumventing the Safety Net provisions could face more severe penalties, including fines or legal action, which could potentially escalate to criminal charges if the breach is deemed to be of a significant nature.
In summary, the National Health (Pharmaceutical Benefits) Regulations (Amendment) introduces a new monetary Safety Net limit for the PBS, replacing the previous numerical prescription limit. These changes are designed to streamline the administration of pharmaceutical benefits and ensure equitable treatment of all concessional beneficiaries. Compliance with these regulations is mandatory for all parties involved, with potential civil or criminal consequences for non-compliance, although the specific penalties are not detailed in the explanatory statement.